首页> 外国专利> Soluble recombinant antigen protein of porcine epidemic diarrhea virus and vaccine composition for preventing or treating porcine epidemic diarrhea comprising the same

Soluble recombinant antigen protein of porcine epidemic diarrhea virus and vaccine composition for preventing or treating porcine epidemic diarrhea comprising the same

机译:猪流行性腹泻病毒的可溶性重组抗原蛋白和用于预防或治疗猪流行性腹泻的疫苗组合物

摘要

The present invention relates to a porcine epidemic diarrhea virus-derived water-soluble recombinant antigen protein, and to a vaccine composition including the same for preventing or treating porcine epidemic diarrhea. To prevent porcine epidemic diarrhea (PED), a subunit vaccine has been developed as a strategy capable of more safely, economically, and rapidly dealing with occurrence of diseases. A conventional attenuated live vaccine is burdensome due to long-term successive culturing (100 times) in animal cells, so it is difficult to rapidly response to the epidemicity of a new mutated virus. However, the subunit vaccine of the present invention can be produced through a simple substitution of a mutated gene sequence in a cloning vector, so a rapid response can be made. Accordingly, the present invention is expected to be used as an oral vaccine along with an injection vaccine or a vaccine carrier for preventing or treating porcine epidemic diarrhea as an animal medical product.
机译:猪流行性腹泻病毒来源的水溶性重组抗原蛋白及其疫苗组合物技术领域本发明涉及猪流行性腹泻病毒来源的水溶性重组抗原蛋白,以及涉及用于预防或治疗猪流行性腹泻的疫苗组合物。为了预防猪流行性腹泻(PED),已经开发了亚单位疫苗作为能够更安全,经济和快速处理疾病发生的策略。常规的减毒活疫苗由于在动物细胞中长期连续培养(100次)而非常繁重,因此难以快速响应新突变病毒的流行。然而,本发明的亚单位疫苗可以通过在克隆载体中简单地突变基因序列的替代来生产,因此可以做出快速反应。因此,期望本发明与预防或治疗作为动物医疗产品的猪流行性腹泻的注射疫苗或疫苗载体一起用作口服疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号